Follow The Filings

AGIO Agios Pharmaceuticals

Agios Pharmaceuticals earnings company data as of 10:00 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by AGIO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AGIO insider trades
  • None no insider bought on the open market
  • $152K sold by 1 insider outside a trading plan
  • $1.2M sold by 2 insiders under 10b5-1 plans
  1. Sarah Gheuens Chief Medical Officer
    Planned sale
    $914K 30,000 shares at $30.48 35% of stake
    Traded Aug 4 Filed Aug 6
    ↗
  2. Theodore James Washburn Jr. Principal Accounting Officer
    Sale
    $152K 5,272 shares at $28.88 86% of stake
    Traded Mar 3 Filed Mar 5
    ↗
  3. David Scadden Director
    Planned sale
    $8,768 200 shares at $43.84 1.1% of stake
    Traded Nov 12, 2025 Filed Nov 14, 2025
    ↗
  4. Sarah Gheuens Chief Medical Officer
    Planned sale
    $107K 2,454 shares at $43.78 3.8% of stake
    Traded Nov 11, 2025 Filed Nov 13, 2025
    ↗
  5. Sarah Gheuens Chief Medical Officer
    Planned sale
    $8,762 200 shares at $43.81 0.3% of stake
    Traded Oct 30, 2025 Filed Nov 3, 2025
    ↗
  6. Sarah Gheuens Chief Medical Officer
    Planned sale
    $145K 3,302 shares at $43.92 5.1% of stake
    Traded Oct 27, 2025 Filed Oct 29, 2025
    ↗
  7. David Scadden Director
    Planned sale
    $8,200 200 shares at $41.00 1.1% of stake
    Traded Oct 8, 2025 Filed Oct 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 49 option exercises, 35 sales to cover taxes, and 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.